Clinical Trials List
Protocol NumberONO-4538-44/CA209649
Completed
2017-01-17 - 2024-12-31
Phase III
Terminated2
-
Trial Applicant
PPD DEVELOPMENT (HK) LIMITED
-
Sponsor
-
Trial scale
-
Update
2026/02/01
Investigators and Locations
Co-Principal Investigator
- Rheun-Chuan Lee Division of Radiology
- Yee Chao Division of Hematology & Oncology
- Chung-Pin Li Division of Hematology & Oncology
- Ming-Huang Chen Division of Hematology & Oncology
- San-Chi Chen Division of Hematology & Oncology
The Actual Total Number of Participants Enrolled
0 Terminated
Co-Principal Investigator
- Wen-Chi Chou Division of Hematology & Oncology
- Hung-Chih Hsu Division of Hematology & Oncology
The Actual Total Number of Participants Enrolled
0 Terminated
Condition/Disease
Objectives
Test Drug
Active Ingredient
Dosage Form
Dosage
Endpoints
Inclution Criteria
The Estimated Number of Participants
-
Taiwan
8 participants
-
Global
2032 participants
